High-Dose Nitroglycerin for Prevention of Coronary Artery Spasm During Arrhythmia Ablation.
Le Christina C, Saksa Dane D, Patel Komal K, Harvey Reed R et al.
Eisai Co., Ltd. · 小分子 · 小分子
nitroglycerin 是一种小分子,由Eisai Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。
| 公司 | Eisai Co., Ltd. |
| 药物类别 | 小分子 |
| 给药途径 | Transdermal |
| 状态 | Approved |
nitroglycerin 针对 2 个适应症,涉及 1 个治疗领域。
| 治疗领域 | 疾病/病症 | 分期 |
|---|---|---|
| Cardiac disorders | Angina pectoris | ✓ Approved |
| Cardiac disorders | Cardiac failure | ✓ Approved |
Le Christina C, Saksa Dane D, Patel Komal K, Harvey Reed R et al.
Zhao Huan H, Song Xiuduo X, Yang Weilu W, Hu Yiwen Y et al.
Energetic composites with high solid content are prone to microcracking and interfacial debonding, which can compromise mechanical integrity and service reliability. To address these long-standing durability challenges, herein, a self-healing polyurethane with hydrogen bonds and disulfide bonds (PUHD) was designed by integrating hydrogen-bond reorganization with dynamic disulfide-bond exchange. PUHD was synthesized using polytetramethylene ether glycol (PTMEG) as the soft segment and isophorone diisocyanate (IPDI) and 4,4'-dihydroxydiphenyl disulfide (DHDPS) as hard-segment components. FT-IR, Raman, XRD, GPC, and DSC analyses confirmed the successful construction of a predominantly amorphous dual dynamic network with suitable chain mobility and thermal stability for energetic-composite applications. The neat PUHD exhibited a hardness of 0.94 MPa and a storage modulus of 3.15 MPa at 20 °C and 5 Hz; surface cracks disappeared within 24 h at ambient temperature, and the storage-modulus recovery reached approximately 97%. In sample filler-containing composites, increasing solid content enhanced hardness and modulus but restricted polymer-chain mobility, thereby slowing crack repair and reducing healing recovery. In nitrocellulose/nitroglycerin (NC/NG)-containing composites, the visible crack closure could be achieved within 24 h, while maintaining useful mechanical properties after self-healing. Notably, JQ-e showed the highest initial hardness of 2.69 MPa and retained 2.19 MPa after healing. These findings collectively demonstrate that the synergistic dynamic network not only enables efficient room-temperature crack repair but also preserves adequate mechanical reinforcement, thus offering a viable pathway toward more reliable energetic-composite formulations.
Otsuka Shinya S, Chiba Yasuyuki Y, Otsuka Kenta K, Shimazu Kyo K et al.
The combination of cisplatin and etoposide is a standard therapy for small cell lung cancer; however, ischemic heart disease is a known complication. We report a rare case of effort angina pectoris that worsened during initial treatment of small cell lung cancer with etoposide. A 73-year-old Asian male was admitted to our hospital with effort angina. Coronary angiography revealed severe stenosis with significant calcification of the proximal right coronary artery. Computed tomography revealed a 21-mm-sized nodule in the right upper lobe and hilar lymphadenopathy suggestive of lung cancer. The patient underwent thoracoscopic wedge resection before coronary revascularization, and intraoperative findings indicated a small cell carcinoma with hilar lymph node metastases. Early postoperative definitive treatment consisting of chemotherapy with cisplatin plus etoposide and accelerated hyperfractionated radiation was planned. During the first chemotherapy session, on postoperative day 7, the patient complained of chest pain, and an electrocardiogram showed slight ST depression in leads V5 and V6 while receiving etoposide; nitroglycerin improved his symptoms. Although treatment was resumed with the administration of nicorandil the next day, the same symptoms were observed during the infusion of etoposide. Accordingly, chemoradiation therapy was suspended and revascularization of the right coronary artery was performed. Etoposide and cisplatin were readministered 3 days after revascularization, without any chest symptoms. Chemotherapy for malignant tumors carries the risk of progression to coronary artery disease. To prevent serious ischemic events, sufficient discussions between oncologists and cardiologists and careful observation of chest symptoms are needed.
Lu Jing J, Zhu Chenlu C
Central sensitization is the core pathological mechanism driving the occurrence and chronification of chronic migraine (CM). Transient Receptor Potential Canonical 5 (TRPC5) channel is critically involved in the modulation of multiple pain disorders and central sensitization. However, the specific regulatory role and precise molecular mechanism of TRPC5 in the progression of acute and chronic migraine remain unclear. This study aimed to explore the potential function of TRPC5 and its downstream signaling cascade in nitroglycerin (NTG)-induced migraine-like central sensitization, so as to provide novel preclinical evidence for migraine pathogenesis and targeted intervention. A repetitive NTG intraperitoneal injection protocol was applied to establish a mouse model mimicking acute migraine nociceptive responses and chronic migraine central sensitization. Migraine-like behavioral phenotypes, including mechanical allodynia, thermal hyperalgesia and light-aversive behavior, were evaluated at both acute and chronic modeling stages. qRT-PCR and Western blot were performed to detect TRPC5 mRNA and protein expression in the primary somatosensory (SSP) cortex. Immunofluorescence staining was used to verify the neuronal localization of upregulated TRPC5 and assess the activation status of cortical neurons and microglia. Pharmacological interventions with TRPC5 selective antagonist AC1903 and phosphoinositide 3-kinase-protein kinase B (PI3K-Akt) inhibitor LY294002 were applied to validate the regulatory relationship among TRPC5, PI3K-Akt signaling and purinergic receptor P2X7/interleukin-1 beta (P2X7R/IL-1β)inflammatory axis. Repeated NTG challenge induced robust migraine-like behaviors, prominent neuronal hyperactivation and sustained central sensitization within the SSP cortex. TRPC5 mRNA and protein were markedly increased mainly in SSP cortical neurons. NTG also triggered microglial overactivation and upregulated P2X7R and IL-1β. AC1903-mediated TRPC5 inhibition alleviated acute and chronic migraine-like phenotypes, blunted neuronal and microglial activation, suppressed PI3K-Akt overactivation and reduced P2X7R/IL-1β expression. LY294002 blockade of PI3K-Akt recapitulated these protective effects, attenuating sensory hypersensitivity and neuroinflammation. TRPC5 mediates NTG-induced migraine central sensitization. Neuronal TRPC5 upregulation activates PI3K-Akt signaling, inducing neuronal hyperexcitability, microglial overactivation and P2X7R/IL-1β neuroinflammation. This TRPC5-dependent axis controls acute nociception and chronic migraine progression. Our findings uncover neuron-microglia crosstalk and support TRPC5 as a preclinical therapeutic target for migraine.
Ullah Waqas W, Janga Chaitra C, Foster Michael M, Nugooru Sudeep S et al.
Transradial coronary catheterization is associated with a reduced risk of bleeding and vascular complications. Prior studies have evaluated nitroglycerin to improve transradial access by vasodilating the radial artery, but the optimal route of administration for preprocedural arterial dilation remains unclear. In the RADial Trial (Radial Artery Dilatation Trial) patients undergoing transradial coronary catheterization were randomized in a double-blind fashion to receive either a placebo or topical nitroglycerin ointment (nitropaste). The primary outcome was the mean change in radial artery dimensions, assessed using paired t tests. Categorical outcomes were analyzed using odds ratio (OR) with 95% CI. A total of 260 patients (130 placebo, 130 nitroglycerin) were enrolled. Nitropaste significantly increased the mean diameter (2.65±0.6 versus 2.48±0.6 mm), circumference (8.37±1.63 versus 7.77±1.66) and cross-sectional area (5.63±2.28 versus 4.94±2.0 mm) of the radial artery, whereas no significant difference was observed in the placebo arm. Nitropaste was associated with a significant reduction in the number of skin punctures and risk of vasospasm (OR 0.34 [95% CI, 0.13-0.91], P=0.04). There was no significant difference between nitropaste and placebo groups in the odds of hematoma (OR, 0.32 [95% CI, 0.03-3.1], P=0.61), crossover to femoral access (OR, 2.29 [95% CI, 0.9-5.8], P=0.12), need for ultrasound-guided access (OR, 0.39 [95% CI, 0.13-1.15], P=0.13), and hypotension or headache (OR, 1.5 [95% CI, 0.24-9.2], P=1.0). Preprocedural administration of nitropaste significantly increases radial artery size and reduces the risk of vasospasm without causing headache or hypotension. https://clinicaltrials.gov/study/NCT05239013.
Wei Diana Y DY, Zelaya Fernando O FO, O'Daly Owen O, Goadsby Peter J PJ
Cluster headache is one of the most painful known disorders. Cluster headache sufferers compare the extreme unilateral pain to labour pains and gunshot wounds. Given the many logistical challenges of capturing spontaneous cluster headache attacks, only a handful of neuroimaging studies have successfully captured such attacks. Intravenous nitroglycerin (NTG) reliably induces cluster headache attacks in a controlled setting, thereby enabling investigation of resting-state functional connectivity during the attack stage. Cluster headache patients aged 18-60 years were recruited from both the population and tertiary headache clinics. Consented participants received either 0.5 µg/kg/min NTG or placebo infusion for 20 min. Structural T1, T2 and FLAIR sequences and resting state blood oxygen level dependent contrast (BOLD) time series were obtained at baseline (pre-infusion) and during headache. A total of 16 paired headache (NTG-infusion) and placebo scans were analysed. The functional connectivity was assessed for three pre-determined seeds: thalamus, ACC and insula. A two-factor (time and treatment), repeated measures 2 × 2 ANOVA model was used to assess main effects and interactions. Significant changes in functional connectivity between the contralateral amygdala (T = 3.47, peak connectivity change at 30, 0, -20, P < 0.001), and hippocampus (T = 4.33, peak connectivity change at 28, -8, -20, P < 0.001) and ipsilateral cerebellum culmen (T = 5.13, peak connectivity change at -14, -30, -18, P < 0.001), with respect to the anterior insula ipsilateral to the pain side. These findings suggest reconfiguration of salience, limbic, cerebellar and default mode networks during the cluster headache attack state and implicate the cerebellum in trigeminal nociceptive processing.
注册免费账户还可查看另外 9996 篇文献
免费注册查看全部文献 →